✦ LIBER ✦

Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)

✍ Scribed by Lara E. Sucheston; Hua Zhao; Song Yao; Gary Zirpoli; Song Liu; William E. Barlow; Halle C. F. Moore; G. Thomas Budd; Dawn L. Hershman; Warren Davis; Gregory L. Ciupak; James A. Stewart; Claudine Isaacs; Timothy J. Hobday; Muhammad Salim; Gabriel N. Hortobagyi; Julie R. Gralow; Robert B. Livingston; Kathy S. Albain; Daniel F. Hayes; Christine B. Ambrosone

Book ID: 106379395
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 357 KB
Volume: 130
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-011-1671-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Role of Tamoxifen in Treatment of Hi

The Role of Tamoxifen in Treatment of High-Risk, Node-Negative Breast Cancer Patients: Results of a Phase III Intergroup Trial (SWOG 8897, INT-102)1

📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 79 KB

Rationale and Design of a Phase III Tria

Rationale and Design of a Phase III Trial of Adjuvant Sequential Epirubicin/Cyclophosphamide and Taxane Versus Concurrent Epirubicin/Taxane in Operable Node-Positive Breast Cancer

✍ Edith A. Perez 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 116 KB

Feasibility and validity of the Patient

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02

✍ Kojiro Shimozuma; Yasuo Ohashi; Ayano Takeuchi; Toshihiko Aranishi; Satoshi Mori 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 592 KB

A randomised phase III intergroup trial

A randomised phase III intergroup trial comparing high-dose infusional 5-fluorouracil with or without folinic acid with standard bolus 5-fluorouracil/folinic acid in the adjuvant treatment of stage III colon cancer: The Pan-European Trial in Adjuvant Colon Cancer 2 study

✍ Köhne, Claus-Henning; Bedenne, Laurent; Carrato, Alfredo; Bouché, Olivier; Popov 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 373 KB

762 Prognostic and Predictive Value of T

762 Prognostic and Predictive Value of TP53 Mutations in Node-positive Breast Cancer Patients Treated with Anthracycline-or Anthracycline/taxane Based Adjuvant Therapy – Results From the BIG 02-98 Phase III Trial

✍ M. Olivier; L. Fernández-Cuesta; C. Oakman; E. Quinaux; M.S. Dolci; P.A. Francis 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Can treatment with Cocculine improve the

Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial

✍ David Pérol, Jocelyne Provençal, Anne-claire Hardy-Bessard, David Coeffic… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 199 KB